307 related articles for article (PubMed ID: 11656322)
1. Protecting us to death: women, pregnancy, and clinical research trials.
Charo RA
St Louis Univ Law J; 1993; 38(1):135-87. PubMed ID: 11656322
[No Abstract] [Full Text] [Related]
2. Gender matters: implications for clinical research and women's health care.
Rothenberg KH
Houst Law Rev; 1996 Symposium; 32(5):1201-72. PubMed ID: 11660524
[No Abstract] [Full Text] [Related]
3. Off the pedestal and into the arena: toward including women in experimental protocols.
Gorenberg H; White A
Rev Law Soc Change; 1991-1992; 19(1):205-46. PubMed ID: 11659599
[No Abstract] [Full Text] [Related]
4. Women's and fetal rights and interests: ethical aspects.
Fletcher JC
Food Drug Law J; 1993; 48(2):213-21. PubMed ID: 11653145
[No Abstract] [Full Text] [Related]
5. Fetal protection and freedom of contract.
Paul EF
Public Aff Q; 1992 Jul; 6(3):305-26. PubMed ID: 11652079
[No Abstract] [Full Text] [Related]
6. The invisible woman: gender bias in medical research.
Keville TD
Womens Rights Law Report; 1994; 15():123-42. PubMed ID: 11660409
[No Abstract] [Full Text] [Related]
7. Exclusion of pregnant women from research protocols: unethical and illegal.
Hall JK
IRB; 1995; 17(2):1-3. PubMed ID: 11653053
[No Abstract] [Full Text] [Related]
8. There is no women's health crisis.
Satel SL
Public Interest; 1998; 130():21-33. PubMed ID: 11658109
[No Abstract] [Full Text] [Related]
9. Women and HIV/AIDS research: the barriers to equity.
Levine C
IRB; 1991; 13(1-2):18-22. PubMed ID: 11659324
[No Abstract] [Full Text] [Related]
10. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials.
Annas GJ
Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162
[No Abstract] [Full Text] [Related]
11. Making experimental drugs available for AIDS treatment.
Krim M
AIDS Public Policy J; 1987; 2(2):1-5. PubMed ID: 11650026
[No Abstract] [Full Text] [Related]
12. HIV, women, and access to clinical trials: tort liability and lessons from DES.
Mastroianni AC
Duke J Gend Law Policy; 1998; 5(1):167-91. PubMed ID: 11979601
[No Abstract] [Full Text] [Related]
13. Looking beyond judicial deference to agency discretion: a fundamental right of access to RU 486?
Silverberg EA
Brooklyn Law Rev; 1994; 59(4):1551-615. PubMed ID: 11656497
[No Abstract] [Full Text] [Related]
14. Women's Health Law Symposium, Rutgers School of Law-Newark, April 6, 1994.
Keville T; Johnson TL; Epstein SS; Podhorin R; Swanston SF
Womens Rights Law Report; 1994; 16(1):17-41. PubMed ID: 11654984
[No Abstract] [Full Text] [Related]
15. The toxic workplace: Title VII protection for the potentially pregnant person.
Andrade VM
Harv Womens Law J; 1981; 4(1):71-105. PubMed ID: 11649449
[No Abstract] [Full Text] [Related]
16. Women of childbearing potential in clinical research: perspectives on NIH policy and liability issues.
Hayunga EG; Rothenberg KH; Pinn VW
Food Drug Cosmet Med Device Law Dig; 1996 Jan; 13(1):7-11. PubMed ID: 11660302
[No Abstract] [Full Text] [Related]
17. Fetal protection policies in the workplace: continuing controversy in light of Johnson Controls.
Blank R
Politics Life Sci; 1992 Aug; 11(2):215-29. PubMed ID: 11659520
[No Abstract] [Full Text] [Related]
18. Women in clinical trials: an introduction.
Merkatz RB
Food Drug Law J; 1993; 48(2):161-6. PubMed ID: 11653138
[No Abstract] [Full Text] [Related]
19. Gender equity in research.
Taylor C
J Womens Health; 1994 Jun; 3(3):143-53. PubMed ID: 11659807
[No Abstract] [Full Text] [Related]
20. Shared interests: promoting healthy births without sacrificing women's liberty.
Johnsen D
Hastings Law J; 1992 Mar; 43(3):569-614. PubMed ID: 11652106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
